Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    22670904 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS)
Conditions: Basal Cell Nevus Syndrome;   Gorlin Syndrome
Intervention: Drug: GDC-0449
2 Recruiting Study Evaluating the Efficacy of Oral Vismodegib in Various Histologic Subtypes
Condition: Basal Cell Carcinoma
Intervention: Drug: vismodegib (150 mg PO daily)
3 Recruiting To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell Carcinoma
Condition: Carcinoma, Basal Cell
Interventions: Drug: Vismodegib;   Radiation: Radiotherapy

Study has passed its completion date and status has not been verified in more than two years.